Recent Cases Provide Hope For Reverse-Payment Defendants
Over four years have now passed since the U.S. Supreme Court shook up the pharmaceutical industry by ruling in FTC v. Actavis Inc. that "large and unjustified" payments from brand manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article